You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 196201 - 196210 of 207728 results
  1. Displacement Chromatography of Coagulation Proteins

    SBC: ZYMEQUEST, INC.            Topic: N/A

    It is proposed that coagulation factor proteins (VII, VIII, and IX) be purified by high resolution displacement chromatography directly from human plasma. Preliminary data shows that broad affinity displacers are effective in substantially purifying these proteins from each other and other plasma proteins. The displacer affinities that are effective in spacing these proteins will be determined and ...

    SBIR Phase I 1993 Department of Health and Human Services
  2. The Development of a Refrigerated Platelet Product

    SBC: ZYMEQUEST, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Our long term aim is to develop a galactosylated and sialylated platelet product that can be stored in the cold in order to prolong shelf life and minimize risk of bacterial growth. Currently, platelets can only be stored at room temperature as platelets stored in the cold disappear rapidly from the circulation after transfusion. Storage at room temperature (RT ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  3. SBIR Phase I: Bioluminescence Resonance Energy Transfer Assays for Clinical Chemistry

    SBC: ZYMERA, INC.            Topic: BT

    This Small Business Innovation Research (SBIR) Phase I research project aims to develop a point-of-care assay for creatine kinase, an important toxicity biomarker, to screen for adverse drug reactions (ADRs) using whole blood. The assay will utilize bioluminescent resonance energy transfer (BRET) probes incorporating quantum dots. The proposed technology is likely to impact toxicity testing, allo ...

    SBIR Phase I 2007 National Science Foundation
  4. STTR Phase I: Non-Toxic Nanoparticles for BRET-Based Molecular Imaging

    SBC: ZYMERA, INC.            Topic: MM

    This award is funded under the American Recovery and Reinvestment Act of 2009 (Public Law 111-5). This Small Business Technology Transfer (STTR) Phase I project will result in the demonstration of non-toxic multi-modality nanoparticle-based molecular probes for in vivo imaging. The objective of the Phase I project is to demonstrate the synthesis and coating of luminescent bismuth sulfide nanopart ...

    STTR Phase I 2009 National Science Foundation
  5. SBIR Phase I: Bioluminescence Resonance Energy Transfer Probes for Molecular Imaging

    SBC: ZYMERA, INC.            Topic: BC

    This Small Business Innovation Research (SBIR) Phase I project will demonstrate the detection of an established target in cancer diagnosis and treatment using new targeted Bioluminescence Resonance Energy Transfer to Quantum Dots (BRET-QD) technology. BRET-QD offers substantial advantages over fluorescence or luminescence imaging by: (1), circumventing the need for external illumination while deli ...

    SBIR Phase I 2009 National Science Foundation
  6. N/A

    SBC: ZYMETX, INC.            Topic: N/A

    N/A

    SBIR Phase I 2000 Department of Health and Human ServicesNational Institutes of Health
  7. ETHNOBOTANICAL ANTI-RESPIRATORY SYNCYTIAL VIRUS DRUGS

    SBC: ZYMETX, INC.            Topic: N/A

    Lower respiratory tract infections such as bronchiolitis and pneumonia in pediatrics and some adults are caused by respiratory syncytial virus. The therapies include the controversial ribavirin for treatment or humanized RSV monoclonal antibodies (Synagis) for prevention. The cost per season for Synagis prophylaxis is about US$ 5,000. In the absence of an effective vaccine, RSV remains a serious h ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  8. DEVELOPMENT OF INHIBITORS AGAINST HCV INFECTION

    SBC: ZYMETX, INC.            Topic: N/A

    DESCRIPTION (Provided by applicant): Hepatitis C viral infection is the most common chronic bloodborne infection in the United States. There are about 36,000 new infections every year, and 25-30 percent of those infections are symptomatic. It is estimated that 3.9 million (1.8 percent) Americans have been infected. Chronic liver disease, which is caused by HCV infection, is the tenth leading cause ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
  9. ETHNOBOTANICAL ANTI-RESPIRATORY SYNCYTIAL VIRUS DRUGS

    SBC: ZYMETX, INC.            Topic: N/A

    Lower respiratory tract infections such as bronchiolitis and pneumonia in pediatrics and some adults are caused by respiratory syncytial virus. The therapies include the controversial ribavirin for treatment or humanized RSV monoclonal antibodies (Synagis) for prevention. The cost per season for Synagis prophylaxis is about US$ 5,000. In the absence of an effective vaccine, RSV remains a serious h ...

    SBIR Phase II 2002 Department of Health and Human ServicesNational Institutes of Health
  10. CLONING AND EXPRESSING HUMAN COLONY STIMULATING FACTOR

    SBC: Zymogenetics Inc            Topic: N/A

    THE GOAL OF THE PROJECT IS THE DEVELOPMENT OF A COMMERCIALLY FEASIBLE SYSTEM FOR THE PRODUCTION OF HUMAN GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR (GMCSF) FOR USE AS A THERAPEUTIC AGENT IN THE TREATMENT OF PATIENTS WHOSE IMMUNE SYSTEM HAS BEEN SUPPRESSED AS A RESULT OF TREATMENT WITH RADIATION THERAPY OR CHEMOTHERAPEUTIC AGENTS. IN PHASE I THE DNA CODING SEQUENCE FOR GMCSF WILL BE CLONED AN ...

    SBIR Phase II 1987 Department of Health and Human Services
US Flag An Official Website of the United States Government